At a glance
- Originator Bristol-Myers Squibb
- Class Antidepressants; Anxiolytics
- Mechanism of Action Corticotropin releasing factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder
Most Recent Events
- 02 May 2000 No-Development-Reported for Anxiety disorders in USA (Unknown route)
- 02 May 2000 No-Development-Reported for Depression in USA (Unknown route)
- 26 May 1997 New profile